Risk factors for preterm birth among HIV-infected pregnant ugandan women randomized to lopinavir/ritonavir-or efavirenz-based antiretroviral therapy
Journal of Acquired Immune Deficiency Syndromes, Volume 67, No. 2, Year 2014
Notification
URL copied to clipboard!
Background: Protease inhibitor-based antiretroviral therapy (ART) has been associated with preterm birth in some studies. We examined risk factors for preterm birth among women randomized to lopinavir/ritonavir (LPV/r)- or efavirenz (EFV)-based ART.